Verena Wagner

804 total citations
12 papers, 199 citations indexed

About

Verena Wagner is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Verena Wagner has authored 12 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Verena Wagner's work include Diabetes and associated disorders (3 papers), Diabetes Management and Research (3 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). Verena Wagner is often cited by papers focused on Diabetes and associated disorders (3 papers), Diabetes Management and Research (3 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). Verena Wagner collaborates with scholars based in Germany, United Kingdom and Estonia. Verena Wagner's co-authors include Jesús Gil, Paul‐Martin Holterhus, Dirk Hose, Bernard Klein, Andreas Neu, Beate Karges, Alwin Krämer, Iris Breitkreutz, Ralph Ziegler and Klaus Podar and has published in prestigious journals such as Genes & Development, Oncogene and Annals of the Rheumatic Diseases.

In The Last Decade

Verena Wagner

10 papers receiving 192 citations

Peers

Verena Wagner

MB

ONCOL

PRM

PHYSI

EDM

Atsuya Fujito Japan

Tonia Kim United States

Darko Katalinić Croatia

Gemma Petts United Kingdom

Angelique Levert‐Mignon Australia

Helen Zemack Sweden

Georgi Manukjan Germany

Andi Zhao China

Erika Pedone Italy

Veronika Kanitz Germany

Atsuya Fujito Japan

Verena Wagner

98 ×1.4

MB

68 ×1.3

ONCOL

30 ×0.7

PRM

35 ×0.9

PHYSI

15 ×0.5

EDM

Citations per year, relative to Verena Wagner Verena Wagner (= 1×) peers Atsuya Fujito

Countries citing papers authored by Verena Wagner

Since Specialization

Citations

This map shows the geographic impact of Verena Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Wagner more than expected).

Fields of papers citing papers by Verena Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Wagner. The network helps show where Verena Wagner may publish in the future.

Co-authorship network of co-authors of Verena Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Wagner. A scholar is included among the top collaborators of Verena Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Wagner. Verena Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Guerrero, Ana, Andrew J. Innes, Pierre‐François Roux, et al.. (2022). 3-Deazaadenosine alleviates senescence to promote cellular fitness and cell therapy efficiency in mice. Nature Aging. 2(9). 851–866. 10 indexed citations

2.

Innes, Andrew J., Bin Sun, Verena Wagner, et al.. (2021). XPO7 is a tumor suppressor regulating p21^CIP1-dependent senescence. Genes & Development. 35(5-6). 379–391. 14 indexed citations

3.

Hinterleitner, Martina, Bence Sipos, Verena Wagner, et al.. (2021). Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies. Cancers. 13(10). 2286–2286. 5 indexed citations

4.

Wagner, Verena & Jesús Gil. (2020). Senescence as a therapeutically relevant response to CDK4/6 inhibitors. Oncogene. 39(29). 5165–5176. 93 indexed citations

5.

Neu, Andreas, Thomas Danne, Axel Dost, et al.. (2020). Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Diabetologie und Stoffwechsel. 15(S 01). S51–S64. 2 indexed citations

6.

Neu, Andreas, Thomas Danne, Axel Dost, et al.. (2019). Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children andAdolescents. Experimental and Clinical Endocrinology & Diabetes. 127(S 01). S39–S72. 33 indexed citations

7.

Neu, Andreas, Thomas Danne, Axel Dost, et al.. (2019). Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Diabetologie und Stoffwechsel. 14(S 02). S153–S166. 1 indexed citations

8.

Werner, Christoph R., Verena Wagner, Bence Sipos, et al.. (2016). Akute Nierenschädigung bei Leberinsuffizienz – Fall 10/2016. DMW - Deutsche Medizinische Wochenschrift. 141(21). 1559–1559. 5 indexed citations

9.

Wagner, Verena, et al.. (2015). Recurrent pyogenic cholangitis as a differential diagnosis in biliary tract diseases. Zeitschrift für Gastroenterologie. 53(9). 1087–1090. 2 indexed citations

10.

Wagner, Verena, Dirk Hose, Anja Seckinger, et al.. (2014). Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1. Oncotarget. 5(21). 10237–10250. 21 indexed citations

11.

Wagner, Verena. (2008). A King(dom) for a Stage: The War Body In and As Performance. Surrey Research Insight Open Access (The University of Surrey).

12.

Wagner, Verena, et al.. (1955). Agglutinins and Incomplete Antibodies after a Single Antigenic Inoculation in Normal and Rheumatic Individuals. Annals of the Rheumatic Diseases. 14(3). 243–250. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact